vs
Side-by-side financial comparison of Legacy Education Inc. (LGCY) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Legacy Education Inc. is the larger business by last-quarter revenue ($19.2M vs $12.6M, roughly 1.5× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 10.6%, a 240.0% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 40.7%).
Legacy Education Inc. is a professional educational service provider focused on financial literacy, real estate investment, entrepreneurship, and personal wealth management training programs. It mainly serves individual learners across North America, Europe and select Asia-Pacific markets, offering both in-person workshops and online digital courses to help users build practical financial and business skills.
LGCY vs SPRO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $12.6M |
| Net Profit | $2.0M | $31.5M |
| Gross Margin | — | — |
| Operating Margin | 13.3% | — |
| Net Margin | 10.6% | 250.7% |
| Revenue YoY | 40.7% | 24080.8% |
| Net Profit YoY | 46.0% | 250.9% |
| EPS (diluted) | $0.15 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $12.6M | ||
| Q3 25 | $19.4M | $0 | ||
| Q2 25 | $18.0M | $0 | ||
| Q1 25 | $18.6M | $12.0K | ||
| Q4 24 | $13.6M | $52.0K | ||
| Q3 24 | $14.0M | $65.0K | ||
| Q2 24 | — | $114.0K | ||
| Q1 24 | — | $140.0K |
| Q4 25 | $2.0M | $31.5M | ||
| Q3 25 | $2.2M | $-7.4M | ||
| Q2 25 | $1.2M | $-1.7M | ||
| Q1 25 | $2.8M | $-13.9M | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $2.1M | $-17.1M | ||
| Q2 24 | — | $-17.9M | ||
| Q1 24 | — | $-12.7M |
| Q4 25 | 13.3% | — | ||
| Q3 25 | 13.9% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 19.7% | -122758.3% | ||
| Q4 24 | 12.2% | — | ||
| Q3 24 | 19.1% | -28604.6% | ||
| Q2 24 | — | -16720.2% | ||
| Q1 24 | — | -9987.1% |
| Q4 25 | 10.6% | 250.7% | ||
| Q3 25 | 11.3% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 15.2% | -115550.0% | ||
| Q4 24 | 10.3% | — | ||
| Q3 24 | 14.9% | -26380.0% | ||
| Q2 24 | — | -15668.4% | ||
| Q1 24 | — | -9049.3% |
| Q4 25 | $0.15 | $0.56 | ||
| Q3 25 | $0.16 | $-0.13 | ||
| Q2 25 | $0.07 | $-0.03 | ||
| Q1 25 | $0.21 | $-0.25 | ||
| Q4 24 | $0.10 | — | ||
| Q3 24 | $0.21 | $-0.32 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $21.1M | $40.3M |
| Total DebtLower is stronger | $660.3K | — |
| Stockholders' EquityBook value | $46.1M | $59.0M |
| Total Assets | $73.1M | $68.9M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.1M | $40.3M | ||
| Q3 25 | $20.6M | $48.6M | ||
| Q2 25 | $20.3M | $31.2M | ||
| Q1 25 | $17.3M | $48.9M | ||
| Q4 24 | $16.9M | $52.9M | ||
| Q3 24 | $21.5M | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
| Q4 25 | $660.3K | — | ||
| Q3 25 | $776.9K | — | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $1.0M | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $758.2K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $46.1M | $59.0M | ||
| Q3 25 | $43.7M | $26.5M | ||
| Q2 25 | $41.0M | $32.8M | ||
| Q1 25 | $39.3M | $33.8M | ||
| Q4 24 | $36.4M | $46.1M | ||
| Q3 24 | $32.6M | $65.5M | ||
| Q2 24 | — | $80.5M | ||
| Q1 24 | — | $96.2M |
| Q4 25 | $73.1M | $68.9M | ||
| Q3 25 | $72.1M | $54.2M | ||
| Q2 25 | $69.2M | $62.1M | ||
| Q1 25 | $67.1M | $77.7M | ||
| Q4 24 | $62.1M | $110.5M | ||
| Q3 24 | $50.6M | $135.2M | ||
| Q2 24 | — | $149.9M | ||
| Q1 24 | — | $167.7M |
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.1M | $-8.4M |
| Free Cash FlowOCF − Capex | $512.7K | — |
| FCF MarginFCF / Revenue | 2.7% | — |
| Capex IntensityCapex / Revenue | 2.8% | — |
| Cash ConversionOCF / Net Profit | 0.52× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $4.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1M | $-8.4M | ||
| Q3 25 | $1.1M | $17.4M | ||
| Q2 25 | $3.0M | $-17.7M | ||
| Q1 25 | $918.7K | $-4.0M | ||
| Q4 24 | $659.0K | $-23.4M | ||
| Q3 24 | $3.2M | $12.8M | ||
| Q2 24 | — | $-18.7M | ||
| Q1 24 | — | $5.9M |
| Q4 25 | $512.7K | — | ||
| Q3 25 | $809.7K | — | ||
| Q2 25 | $2.9M | — | ||
| Q1 25 | $596.6K | — | ||
| Q4 24 | $466.8K | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 16.2% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 21.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.8% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.52× | -0.26× | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 2.45× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
